freeze-thaw raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-25 and is reviewed periodically as new material appears.
Quality verification after reconstitution may include visual inspection, pH measurement, and chromatographic analysis. Reverse-phase high-performance liquid chromatography can reveal degradation peaks, while mass spectrometry can confirm molecular identity. Concentration may be estimated from the weighed peptide mass or determined by amino acid analysis, UV absorbance, or quantitative chromatography. Documentation of solvent, volume, date, and storage conditions supports traceability and reproducibility. Records also help identify when a solution was prepared and whether it has exceeded an established in-house shelf life.
After a dried peptide is dissolved, the resulting solution is treated as a distinct material with its own stability profile. Temperature, pH, ionic strength, and peptide concentration all influence how long the solution remains suitable for its intended laboratory use. Some sequences are prone to oxidation, deamidation, or aggregation. Because these processes vary widely, no single storage condition applies to every peptide. Buffer composition and light exposure can also shift degradation rates.
Aseptic technique matters when the solution will contact cells or biological reagents. Working in a clean environment, using sterile liquids and containers, and minimizing open-vial time reduce the chance of microbial contamination. Filtration through a sterile filter can remove particles and microorganisms, but some filters adsorb peptides and some peptides are retained by certain membrane materials. Compatibility between the peptide, solvent, and filter should be checked when recovery is critical.
Water is common, but not universal; hydrophobic peptides may require organic co-solvents like acetonitrile or dimethyl sulfoxide. Acidic peptides may dissolve better in dilute acetic acid or ammonium hydroxide, while basic peptides may favor slightly acidic conditions. Buffer choice matters because pH can affect charge, solubility, and aggregation. Some peptides require sonication or gentle mixing, whereas vigorous vortexing can cause foaming and surface denaturation. The target concentration is typically calculated from the labeled peptide mass and the volume of solvent added.
Dissolution involves hydration of polar and charged groups, disruption of intermolecular interactions in the lyophilized powder, and transition to a thermodynamically favored solution state. Not all powder dissolves readily; aggregation, incomplete lyophilization, or high molecular weight can slow reconstitution. The resulting solution may contain particulates or oligomers that affect downstream measurements. Researchers often verify complete dissolution by visual inspection and spectrophotometric or chromatographic methods. The relationship between reconstitution conditions and long-term stability remains an active area of study.
| Property | Value | Notes |
|---|---|---|
| Appearance after dissolution | Clear to slightly opalescent solution | Cloudiness or particles may indicate incomplete dissolution, aggregation, or contamination. |
| pH range for stability | Peptide-dependent | Many peptides are most stable near neutral pH, but some require acidic or slightly basic conditions. |
| Common preservative | None for many research uses | Antimicrobial preservatives can alter assays or react with peptides; use depends on application. |
| Typical container material | Borosilicate glass or low-binding plastic | Some peptides adsorb to plastic surfaces; siliconized or low-binding tubes can reduce loss. |
| Common quality check | RP-HPLC, LC-MS, UV absorbance | Identity, purity, and concentration are separate attributes; no single method measures all three. |
Intravenous and oral formulations of acetylcysteine are available for the treatment of paracetamol (acetaminophen) overdose. When paracetamol is taken in large quantities, a toxic minor metabolite called N-acetyl-p-benzoquinone imine (NAPQI) accumulates within the body. It is normally conjugated by glutathione (GSH), but when taken in excess, the body's glutathione reserves are not sufficient to deactivate the toxic NAPQI. This metabolite is then free to react with key hepatic enzymes, thereby damaging liver cells. This may lead to severe liver damage and even death by acute liver failure. Liver necrosis is observed in animals at ~70% GSH depletion, and normal liver GSH is approximately 4 mmol/L. In the treatment of paracetamol (acetaminophen) overdose, acetylcysteine acts to maintain or replenish depleted glutathione reserves in the liver and enhance non-toxic metabolism of acetaminophen. These actions serve to protect liver cells from NAPQI toxicity. It is most effective in preventing or lessening hepatic injury when administered within 8–10 hours after overdose. Research suggests that the rate of liver toxicity is approximately 3% when acetylcysteine is administered within 10 hours of overdose. To decide whether NAC treatment is warranted, the Rumack–Matthew nomogram may be consulted.
Fermentation of Streptomyces avermitilis yields eight closely related avermectin homologues, of which B1a and B1b form the bulk of the products isolated. In a separate chemical step, the mixture is hydrogenated to give ivermectin, which is an approximately 80:20 mixture of the two 22,23-dihydroavermectin compounds. Ivermectin is a macrocyclical lactone.
In its wild-type form, the IDH1 enzyme is active in the cytoplasm and peroxisomes, where it catalyzes the conversion of isocitrate into α-ketoglutarate (α-KG) as part of the citric acid cycle. This process generates NADPH, a vital molecule that supports antioxidant defenses and biosynthetic processes. When mutated, IDH1 undergoes a neomorphic transformation, shifting its function. The altered enzyme converts α-KG into D-2-hydroxyglutarate (D-2HG), an oncometabolite. Elevated D-2HG levels disrupt normal cellular processes by inhibiting α-KG–dependent dioxygenases, leading to epigenetic changes, DNA hypermethylation, and impaired differentiation. Moreover, the mutation redirects NADPH consumption, increasing oxidative stress, which further drives tumor development. The accumulation of D-2HG and elevated oxidative stress play a critical role in reshaping the tumor microenvironment, positioning the R132H mutation as a prime target for IDH inhibitors. These therapies aim to restore regular metabolic functions and reduce tumor aggressiveness, offering a promising avenue for glioma treatment. In addition to being mutated in diffuse gliomas, IDH1 has also been shown to harbor mutations in human acute myeloid leukemia. The IDH1 mutation is considered a driver alteration and occurs early during tumorigenesis, in specific in glioma and glioblastoma multiforme, its possible use as a new tumour-specific antigen to induce antitumor immunity for the cancer treatment has recently been prompted.
Official state government portal Geographic data related to Schleswig-Holstein at OpenStreetMap Chisholm, Hugh, ed. (1911). "Schleswig-Holstein" . Encyclopædia Britannica (11th ed.). Cambridge University Press. Schleswig-Holsteins Ehrenbürgerinnen und Ehrenbürger (Schleswig-Holstein Honorary Citizens, In German)
Sources: en.wikipedia.org
=== No development reported === AB-1224 – microbiome modulator AGX-201 (histamine dihydrochloride salt) – histamine H1 receptor antagonist and histamine H3 receptor agonist Aminolevulinic acid/sodium ferrous citrate (5-ALA-SFC, 5-ALA/SFX; sodium ferrous citrate/aminolevulinic acid; SPP-003) – erythropoiesis stimulant and photosensitizer Aripiprazole transdermal (AQS-1301; transdermal aripiprazole) – dopamine D2 and D3 receptor partial agonist, serotonin 5-HT1A and 5-HT7 receptor partial agonist, serotonin 5-HT2A and 5-HT2B receptor antagonist or inverse agonist, and atypical antipsychotic BAER-101 (AZ-7325; AZD-7325) – selective GABAA α2 and α3 subunit-containing receptor positive allosteric modulator BBP-472 – phosphatidylinositol 3 kinase β (PI3Kβ) inhibitor Fasoracetam co-crystallised (co-crystallised fasoracetam; AEVI-004) – various actions and racetam Guanfacine once-daily (Guanfacine Carrier Wave; SPD-547) – α2-adrenergic receptor agonist KBLP-010 – bacteria replacement and microbiome modulator Oxytocin intranasal (OPN-300; OptiNose oxytocin) – oxytocin receptor agonist Research programme: allosteric modulators - Addex Therapeutics (various) – various actions Research programme: antisense oligonucleotide therapeutics - RogCon U.R (RCUR-313, RCUR-SMP) – voltage-gated sodium channel Nav1.2 expression stimulants Research programme: autism and obesity therapeutics - Berand Neuropharmacology – histone deacetylase inhibitors Research programme: brain development disorder therapeutics - Seaside Therapeutics (STX-110) – metabotropic glutamate mGlu5 receptor antagonists and muscarinic acetylcholine M1 receptor antagonists Research programme: cannabinoid receptor modulators - GW Pharmaceuticals (cannabigerol; CBG) – cannabinoid receptor modulators Research programme: cannabis extract therapeutics - Cannabis Science (CBIS compounds) – cannabinoid receptor modulators Research programme: central nervous system therapeutics - AbbVie/Rugen – undefined mechanism of action Research programme: CNS disorder therapeutics - Promentis Pharmaceuticals – antioxidants, glutamate receptor modulators, SLC7A11 modulators Research programme: CNS disorders therapeutics - Sage Therapeutics (SAGE-105; SGE-202; SGE-301; SGE-516) – GABAA receptor modulators and ionotropic glutamate NMDA receptor modulators Research programme: G protein-coupled receptor modulating small molecules - Omeros Corporation – G protein-coupled receptor modulator and neuromedin U receptor modulator Research programme: GPCR modulators - Nxera Pharma – various actions Research programme: immunomodulating bacteria-based therapeutics - 4D Pharma – bacteria replacements Research programme: metabotropic glutamate receptor 5 antagonists - Roche/Seaside Therapeutics – metabotropic glutamate mGlu5 receptor antagonists Research programme: oxytocin intranasal - Pastorus Pharma – neurotransmitter modulators/oxytocin receptor agonists Research programme: therapeutic autoantibodies - Sengenics – undefined mechanism of action RG-7713 (RG7713) – vasopressin V1A receptor antagonist Tideglusib (AMO-02, NP-031112, NP-12; Nypta, Zentylor) – glycogen synthase kinase 3β (GSK-3β) inhibitor Vafidemstat (ORY-2001) – dual lysine specific demethylase 1 (LSD1) inhibitor and monoamine oxidase B (MAO-B) inhibitor Xenon (NBTX-001) – ionotropic glutamate NMDA receptor antagonist
=== Human growth hormone (hGH) === Human growth hormone is a naturally occurring hormone that is responsible for general body growth in both men and women. hGH helps the body protein while breaking down fat deposits. Too much hGH results in increased muscle mass.
The Industrial Revolution in Japan occurred during the Meiji era. The industrial revolution began around 1870 as Meiji era leaders decided to catch up with the West. The government built its first railroads, improved roads, and inaugurated a land reform program to prepare the country for further development. It inaugurated a new Western-based education system for all young people, sent thousands of students to the United States and Europe, and hired more than 3,000 Westerners to teach modern science, mathematics, technology, and foreign languages in Japan (O-yatoi gaikokujin). In 1871, a group of Japanese politicians known as the Iwakura Mission toured Europe and the US to learn western ways. The result was a deliberate state-led industrialization policy to enable Japan to quickly catch up. Japan developed modern industry through direct state intervention. Government-owned enterprises were important to the development of key economic sectors like railways. Through government connections, major private enterprises received various forms of financial support from the state. Modern industry first appeared in textiles, including cotton and especially silk, which was based in home workshops in rural areas. Due to the importing of new textile manufacturing technology from Europe, between 1886 and 1897, Japan's total value of yarn output rose from 12 million to 176 million yen. In 1886, 62% of yarn in Japan was imported; by 1902, most yarn was produced locally.
=== Circadian rhythm === Wild-type flies show an activity rhythm with a frequency of about a day (24 hours). Benzer and others found mutants with faster and slower rhythms, as well as broken rhythms—flies that move and rest in random spurts. Work over the following 30 years has shown that these mutations (and others like them) affect a group of genes and their products that form a biochemical or biological clock. This clock is found in a wide range of fly cells, but the clock-bearing cells that control activity are several dozen neurons in the fly's central brain. The Nobel Prize in Physiology or Medicine for 2017 was awarded to Jeffrey C. Hall, Michael Rosbash, Michael W. Young for their works using fruit flies in understanding the "molecular mechanisms controlling the circadian rhythm".
== In fiction == In the episode "eps2.3_logic-b0mb.hc" (ep. 5 of season 2) of the drama–thriller television series, Mr. Robot, the protagonist, Elliot, is supposed to be repairing a Tor hidden site which turns out to be a darknet market called "Midland City" styled after the Silk Road for the sale of guns, sex trafficked women, rocket launchers, drugs and hitmen for hire. In the 2016 movie Nerve starring Emma Roberts and Dave Franco, the dark web plays a major role. In Grand Theft Auto Online, players who purchase warehouses and garages for illicit cargo and stolen cars can buy/steal and sell them through trade on the "SecuroServ" syndicate website. After the Biker DLC, players can now purchase buildings for illegal drugs and counterfeit products manufacture, and distribute them through a darknet website called "The Open Road" where law enforcement cannot be notified of the player's trade. In the first arc of the anime series Lupin the 3rd Part V, Lupin III steals digital currency from the "Marco Polo" darknet market.
Sources: en.wikipedia.org
== Peptide fragmentation == Peptides are protonated in positive-ion mode. The proton initially locates at the N-terminus or a basic residue side chain, but because of the internal solvation, it can move along the backbone breaking at different sites which result in different fragments. The fragmentation rules are well explained by some publications. Three different types of backbone bonds can be broken to form peptide fragments: alkyl carbonyl (CHR-CO), peptide amide bond (CO-NH), and amino alkyl bond (NH-CHR).
=== Pharmacokinetics === EBB is said to have a shorter duration than estradiol enantate of about 3 weeks. EBB/DHPA was developed because it was thought that the duration of EBB would be more suitable for use as a once-monthly combined injectable contraceptive than estradiol enantate in estradiol enantate/algestone acetophenide.
Teratogenic effects with therapeutic doses of suvorexant in humans have not been established due to lack of research and available data. Suvorexant is pregnancy category C in the United States. It is unknown whether suvorexant is present in the breast milk, whether it affects lactation in breastfeeding women, or whether it affects breastfed infants. However, suvorexant has been found to be present in mammary milk in rats and this is likely to be the case in humans as well. Suvorexant should be used in pregnant and breastfeeding women only if the potential benefit justifies the potential for harm to the baby.
=== Mixtures === Typically, supercritical fluids are completely miscible with each other, so that a binary mixture forms a single gaseous phase if the critical point of the mixture is exceeded. However, exceptions are known in systems where one component is much more volatile than the other, which in some cases form two immiscible gas phases at high pressure and temperatures above the component critical points. This behavior has been found in systems such as N2-NH3, NH3-CH4, SO2-N2 and n-butane-H2O.. The systems composed by a supercritical fluid and a liquid are named Gas expanded liquids. The critical point of a binary mixture can be estimated as the arithmetic mean of the critical temperatures and pressures of the two components,
=== Indoor air-quality measurements === Measurement of VOCs from the indoor air is done with sorption tubes e. g. Tenax (for VOCs and SVOCs) or DNPH-cartridges (for carbonyl-compounds) or air detector. The VOCs adsorb on these materials and are afterwards desorbed either thermally (Tenax) or by elution (DNPH) and then analyzed by GC–MS/FID or HPLC. Reference gas mixtures are required for quality control of these VOC measurements. Furthermore, VOC emitting products used indoors, e.g. building products and furniture, are investigated in emission test chambers under controlled climatic conditions. For quality control of these measurements round robin tests are carried out, therefore reproducibly emitting reference materials are ideally required. Other methods have used proprietary Silcosteel-coated canisters with constant flow inlets to collect samples over several days. These methods are not limited by the adsorbing properties of materials like Tenax.
Sources: en.wikipedia.org
Most reconstituted peptide solutions are kept cold, often at 2–8 °C for short-term use. Longer storage may require freezing at -20 °C or below, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation or degradation.
Freezing concentrates solutes and can expose peptides to ice interfaces, which may unfold or aggregate some sequences. Repeated cycles amplify these stresses. Aliquoting before freezing reduces the number of cycles a single container experiences.
Yes. Some membrane filters bind peptides, especially hydrophobic or positively charged sequences, reducing the amount recovered. Filter material and pore size should be selected with compatibility in mind. Recovery can be checked by comparing pre- and post-filtration analysis when needed.
Lyophilized peptide is a dry powder made by freeze-drying, while reconstituted peptide is dissolved in a solvent. The dry form generally offers longer storage at appropriate temperatures. Reconstitution introduces water and increases the risk of degradation.